Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications.
about
Managing comorbidities in COPDImpact of airflow limitation in chronic heart failure.Symptoms and impact of symptoms on function and health in patients with chronic obstructive pulmonary disease and chronic heart failure in primary health care.Serial pulmonary function tests to diagnose COPD in chronic heart failurePrognostic value of alveolar volume in systolic heart failure: a prospective observational studyAppropriateness and acceptability of a Tele-Yoga intervention for people with heart failure and chronic obstructive pulmonary disease: qualitative findings from a controlled pilot studyPatients with heart failure and concomitant chronic obstructive pulmonary disease participating in the Heart Failure Pilot Survey (ESC-HF Pilot) - Polish population.Prevalence of airflow obstruction in patients with stable systolic heart failure.Oxygen Uptake Efficiency Slope and Breathing Reserve, Not Anaerobic Threshold, Discriminate Between Patients With Cardiovascular Disease Over Chronic Obstructive Pulmonary Disease.Cardiovascular and Mortality Outcomes in the Elderly With Impaired Cardiac and Pulmonary Function: The Cardiovascular Health Study (CHS)Beta-blockers and health-related quality of life in patients with peripheral arterial disease and COPD.Echocardiography, spirometry, and systemic acute-phase inflammatory proteins in smokers with COPD or CHF: an observational studyUpdate in chronic obstructive pulmonary disease 2008.β-blockers and their mortality benefits: underprescribed in heart failure and chronic obstructive pulmonary disease.Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art.Systolic heart failure in the elderly: optimizing medical management.Developing the model of pulmonary rehabilitation for chronic heart failure.The comorbidity conundrum: a focus on the role of noncardiovascular chronic conditions in the heart failure patient.Heart failure and chronic obstructive pulmonary disease: the challenges facing physicians and health services.Medication management of chronic heart failure in older adults.Chronic obstructive pulmonary disease in heart failure: accurate diagnosis and treatment.Prognosis of heart failure patients with reduced and preserved ejection fraction and coexistent chronic obstructive pulmonary disease.Does Improving Exercise Capacity and Daily Activity Represent the Holistic Perspective of a New COPD Approach?Challenges in the Management of Patients with Chronic Obstructive Pulmonary Disease and Heart Failure With Reduced Ejection Fraction.Heart failure, chronic obstructive pulmonary disease, and asthma: numbers, facts, and challengesBeta-blocker therapy in patients with left ventricular systolic dysfunction and chronic obstructive lung disease in an ambulatory care setting.Primary care burden and treatment of patients with heart failure and chronic obstructive pulmonary disease in Scotland.Occurrence and impact of chronic obstructive pulmonary disease in elderly patients with stable heart failure.Comparison between ATS/ERS age- and gender-adjusted criteria and GOLD criteria for the detection of irreversible airway obstruction in chronic heart failure.Economic burden of chronic obstructive pulmonary disease.The prognostic significance of lung function in stable heart failure outpatients.Emergency department management of acute exacerbations of chronic obstructive pulmonary disease: factors predicting readmission.The prognostic importance of lung function in patients admitted with heart failure
P2860
Q27005858-F6D03DDF-FA5B-4B90-B000-A4B87525C89FQ33603101-75130C50-E8BF-42F8-987F-28E5FFB0AEB4Q33952700-6E25A5E0-4F92-4D58-AB2E-290D5C8B42ABQ34253499-3ECD2D2B-9E1A-44D4-866D-6422E1DAAA1AQ35051006-99EBC750-7153-4C02-9079-A69607DC239EQ35074049-5542CB5B-3362-4C73-97B0-CD7DB25E4B00Q35992082-C0C9889A-F06B-432C-9DBE-FDEE7BFD9521Q36243275-18683FFD-A8D8-4518-B73B-14D6442E784AQ36763063-3DAAC1DF-2449-4631-AC67-E0AFEE6FA7CFQ36836417-E05854FD-6A8E-4D76-8184-E76835BD65CCQ37199663-B1071C46-62EA-499D-990A-3007D601F6FBQ37297427-86FB75DD-B0B5-406E-8F82-21C7006108C6Q37422824-92E275A0-CA01-49A7-B7E2-CB0044ECD1FAQ37822723-7C1F0F79-E28A-4EF0-B9AD-E052DAFAAA89Q37940008-D73DFE80-2B18-49AD-832F-A350DDF012CCQ37946224-5AD3F55C-2F64-4B76-A1E5-FD3C72C01FB9Q37957593-593BF215-A198-44C4-A1F2-187182BF9336Q37993441-60E10C66-978D-41C2-B210-F46AC5304F59Q38119867-8E31B918-735F-4E3A-A755-730C73BFB396Q38126374-FC7C19A4-0D4C-4BEF-8751-CDF8F78B7479Q38262835-BEAA2E6C-919D-49F9-9985-A36C6F16C818Q38481486-B970DB37-1123-41AB-BBF8-724E3A6696CBQ38604749-959769A0-09C9-4332-BCD6-7F26329EB380Q38701409-2E63ADA3-5491-43B2-AE80-C0F421620AFFQ42389709-1FDD8329-8064-48A4-B93B-0FC2BF83E6CDQ42794601-5FA520D5-6E27-44B4-AAB4-C72BC320F44CQ43792082-AEA6B61B-A2C9-4FE8-A69A-82785CD70EC4Q44616969-4E528E04-AF43-4EEB-AF98-FFFA1227C3BAQ45301370-4E8385FA-13A7-462E-94F7-5972D2853217Q45388291-04067EED-90E7-45DB-954D-83FE9A9ADDC0Q47774410-F88FD760-C172-4875-89FF-DCF9983A52F1Q55413850-A8984315-8780-455F-8A17-77C56FCE71BFQ57955824-FC15148D-29E9-42D6-9AB0-0E2AD0766BAD
P2860
Chronic obstructive pulmonary disease in heart failure. Prevalence, therapeutic and prognostic implications.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Chronic obstructive pulmonary ...... c and prognostic implications.
@en
Chronic obstructive pulmonary ...... c and prognostic implications.
@nl
type
label
Chronic obstructive pulmonary ...... c and prognostic implications.
@en
Chronic obstructive pulmonary ...... c and prognostic implications.
@nl
prefLabel
Chronic obstructive pulmonary ...... c and prognostic implications.
@en
Chronic obstructive pulmonary ...... c and prognostic implications.
@nl
P50
P1476
Chronic obstructive pulmonary ...... c and prognostic implications.
@en
P2093
Ricardo Lopes
P304
P356
10.1016/J.AHJ.2007.10.040
P407
P577
2008-03-01T00:00:00Z